Profile
Vasily Andrianov worked as the VP-Clinical Development & Medical Affairs at Inhibrx, Inc. from 2021 to 2024.
He holds a doctorate degree from Pavlov First Saint Petersburg State Medical University.
Former positions of Vasily Andrianov
| Companies | Position | End |
|---|---|---|
| INHIBRX, INC. | Chief Tech/Sci/R&D Officer | 2024-05-29 |
Training of Vasily Andrianov
| Pavlov First Saint Petersburg State Medical University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Inhibrx, Inc.
 Inhibrx, Inc. BiotechnologyHealth Technology Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA. | Health Technology |
- Stock Market
- Insiders
- Vasily Andrianov
